tiprankstipranks
Gilead Sciences, Inc. Shs Unsponsored Canadian Depository Receipt Hedged Reg S (TSE:GILD)
TSX:GILD
Canadian Market
GILD
Gilead Sciences, Inc. Shs Unsponsored Canadian Depository Receipt Hedged Reg S
RESEARCH TOOLSreports
Want to see TSE:GILD full AI Analyst Report?

Gilead Sciences, Inc. Shs Unsponsored Canadian Depository Receipt Hedged Reg S (GILD) Stock News & Sentiment

2 Followers
Gilead Sciences: Core HIV and Liver Franchises Drive EPS Upside and Support Buy Rating Despite Cell Therapy Headwinds
Premium
Ratings
Gilead Sciences: Core HIV and Liver Franchises Drive EPS Upside and Support Buy Rating Despite Cell Therapy Headwinds
13d ago
GILD
Gilead: Durable HIV Franchise and Emerging Oncology Pipeline Support Buy Rating and Upside to $162 Target
Premium
Ratings
Gilead: Durable HIV Franchise and Emerging Oncology Pipeline Support Buy Rating and Upside to $162 Target
21d ago
GILD
Balancing Strategic Oncology Expansion and Execution Risk: Why Gilead’s Tubulis Deal Supports a Hold Rating
Premium
Ratings
Balancing Strategic Oncology Expansion and Execution Risk: Why Gilead’s Tubulis Deal Supports a Hold Rating
28d ago
GILD
Gilead Sciences: Strategic Oncology Expansion and Undervalued Growth Opportunity Driving Buy Rating
Premium
Ratings
Gilead Sciences: Strategic Oncology Expansion and Undervalued Growth Opportunity Driving Buy Rating
28d ago
GILD
Gilead’s Tubulis Acquisition: Building an ADC Oncology Franchise and Enhancing Risk‑Reward for GILD Shares
Premium
Ratings
Gilead’s Tubulis Acquisition: Building an ADC Oncology Franchise and Enhancing Risk‑Reward for GILD Shares
28d ago
GILD
Buy Rating on Gilead Driven by HIV Franchise Momentum and Upside from Yeztugo and Biktarvy
Premium
Ratings
Buy Rating on Gilead Driven by HIV Franchise Momentum and Upside from Yeztugo and Biktarvy
1M ago
GILD
Gilead Sciences: Advancing Long-Acting HIV Franchise Underscores Competitive Edge and Supports Buy Rating
Premium
Ratings
Gilead Sciences: Advancing Long-Acting HIV Franchise Underscores Competitive Edge and Supports Buy Rating
2M ago
GILD
More TSE:GILD News >

News Score - Last 7 Days

Neutral
TSE:GILD
Sector Average
Media Buzz
This Week4 articles
Weekly Average5.75 articles
News Sentiment
This Week100%
Sector Average70%
See how Bullish or Bearish a stock is based on its recent media coverage.

This score is generated using a formula that combines Media Buzz and News Sentiment.

FAQ

What is TSE:GILD’s Media Buzz Sentiment?
4 articles about TSE:GILD were published this week. In an average week, 5.75 articles are published.
    What is TSE:GILD’s weekly average amount of articles?
    In an average week, 5.75 articles about TSE:GILD are published.
      What is TSE:GILD’s News Sentiment?
      100% of articles about TSE:GILD were positive this week, compared to its sector average of 70%.
        Healthcare Stocks that are Trending in the News
        Showing the stocks with the most bullish news sentiment over the past week